Nitric oxide mediates endotoxin-induced hypertriglyceridemia through its action on skeletal muscle lipoprotein lipase.
Picard
F
F
Center for Research on Energy Metabolism, Department of Anatomy and Physiology, School of Medicine, Laval University, Québec, QC, Canada G1K 7P4.
Kapur
S
S
Perreault
M
M
Marette
A
A
Deshaies
Y
Y
D000273:Adipose Tissue / Q000201:enzymology; D000818:Animals; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004926:Escherichia coli; D006146:Guanidines / Q000494:pharmacology; D015228:Hypertriglyceridemia / Q000139:chemically induced*; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008071:Lipoprotein Lipase / Q000037:antagonists & inhibitors*; D051379:Mice; D018345:Mice, Knockout; D018482:Muscle, Skeletal / Q000201:enzymology*; D009569:Nitric Oxide / Q000502:physiology*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors / Q000172:deficiency / Q000502:physiology; D052247:Nitric Oxide Synthase Type II; D051381:Rats; D017207:Rats, Sprague-Dawley; D014280:Triglycerides / Q000097:blood
D004791:Enzyme Inhibitors; D006146:Guanidines; D008070:Lipopolysaccharides; D014280:Triglycerides; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496317:Nos2 protein, mouse; C496318:Nos2 protein, rat; D008071:Lipoprotein Lipase; C004479:pimagedine